HK1223348A1 - 阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物 - Google Patents
阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物Info
- Publication number
- HK1223348A1 HK1223348A1 HK16111559.2A HK16111559A HK1223348A1 HK 1223348 A1 HK1223348 A1 HK 1223348A1 HK 16111559 A HK16111559 A HK 16111559A HK 1223348 A1 HK1223348 A1 HK 1223348A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- same
- agomelatine
- crystals
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- YJYPHIXNFHFHND-UHFFFAOYSA-N agomelatine Chemical compound C1=CC=C(CCNC(C)=O)C2=CC(OC)=CC=C21 YJYPHIXNFHFHND-UHFFFAOYSA-N 0.000 title 1
- 229960002629 agomelatine Drugs 0.000 title 1
- 239000013078 crystal Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Reproductive Health (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2013/080472 WO2015013903A1 (en) | 2013-07-31 | 2013-07-31 | NEW AGOMELATINE p-TOLUENESULFONIC ACID CO-CRYSTAL FORMS AND PREPARATION THEREOF |
| FR1360121A FR3012141B1 (fr) | 2013-10-17 | 2013-10-17 | Nouvelles formes de co-cristaux d'agomelatine et d'acide p-toluenesulfonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PCT/FR2014/051972 WO2015015118A2 (fr) | 2013-07-31 | 2014-07-30 | NOUVELLES FORMES DE CO-CRISTAUX D'AGOMELATINE ET D'ACIDE p-TOLUENESULFONIQUE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1223348A1 true HK1223348A1 (zh) | 2017-07-28 |
Family
ID=51300781
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16110305.1A HK1222167A1 (zh) | 2013-07-31 | 2016-08-30 | 阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物 |
| HK16111559.2A HK1223348A1 (zh) | 2013-07-31 | 2016-10-04 | 阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16110305.1A HK1222167A1 (zh) | 2013-07-31 | 2016-08-30 | 阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物 |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US9663451B2 (zh) |
| EP (1) | EP3036218B1 (zh) |
| JP (1) | JP6525996B2 (zh) |
| AU (1) | AU2014298230C1 (zh) |
| CA (1) | CA2918228C (zh) |
| CY (1) | CY1122959T1 (zh) |
| DK (1) | DK3036218T3 (zh) |
| EA (1) | EA031053B1 (zh) |
| ES (1) | ES2734562T3 (zh) |
| HK (2) | HK1222167A1 (zh) |
| HR (1) | HRP20191119T1 (zh) |
| HU (1) | HUE044798T2 (zh) |
| LT (1) | LT3036218T (zh) |
| ME (1) | ME03388B (zh) |
| MX (1) | MX369301B (zh) |
| NZ (1) | NZ716153A (zh) |
| PL (1) | PL3036218T3 (zh) |
| PT (1) | PT3036218T (zh) |
| RS (1) | RS58778B1 (zh) |
| RU (1) | RU2695609C2 (zh) |
| SG (1) | SG11201600005VA (zh) |
| SI (1) | SI3036218T1 (zh) |
| UA (1) | UA117023C2 (zh) |
| WO (1) | WO2015015118A2 (zh) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498466B2 (en) * | 2004-02-13 | 2009-03-03 | Les Laboratoires Servier | Process for the synthesis and crystalline form of agomelatine |
| CN101481321B (zh) * | 2009-02-27 | 2012-04-18 | 上海医药工业研究院 | 阿戈美拉汀卤化氢复合物及其制备方法 |
| EP2517700B1 (en) * | 2011-04-28 | 2013-07-17 | Zentiva, k.s. | Pharmaceutically acceptable cocrystals of N-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation |
| EP2851363B1 (en) | 2012-05-14 | 2018-01-03 | Shanghai Righthand Pharmtech. Co., Ltd. | Agomelatine acid radical composite, and preparation method and application thereof |
| CN102702041B (zh) * | 2012-05-14 | 2013-08-14 | 上海右手医药科技开发有限公司 | 阿戈美拉汀苯磺酸类复合物及其制备方法 |
-
2014
- 2014-07-30 ES ES14749937T patent/ES2734562T3/es active Active
- 2014-07-30 US US14/908,253 patent/US9663451B2/en active Active
- 2014-07-30 MX MX2016001218A patent/MX369301B/es active IP Right Grant
- 2014-07-30 HU HUE14749937 patent/HUE044798T2/hu unknown
- 2014-07-30 DK DK14749937.0T patent/DK3036218T3/da active
- 2014-07-30 LT LTEP14749937.0T patent/LT3036218T/lt unknown
- 2014-07-30 ME MEP-2019-153A patent/ME03388B/me unknown
- 2014-07-30 WO PCT/FR2014/051972 patent/WO2015015118A2/fr active Application Filing
- 2014-07-30 PT PT14749937T patent/PT3036218T/pt unknown
- 2014-07-30 JP JP2016530589A patent/JP6525996B2/ja not_active Expired - Fee Related
- 2014-07-30 PL PL14749937T patent/PL3036218T3/pl unknown
- 2014-07-30 SG SG11201600005VA patent/SG11201600005VA/en unknown
- 2014-07-30 AU AU2014298230A patent/AU2014298230C1/en not_active Ceased
- 2014-07-30 EP EP14749937.0A patent/EP3036218B1/fr active Active
- 2014-07-30 SI SI201431215T patent/SI3036218T1/sl unknown
- 2014-07-30 RU RU2016106954A patent/RU2695609C2/ru active
- 2014-07-30 NZ NZ716153A patent/NZ716153A/en not_active IP Right Cessation
- 2014-07-30 RS RS20190633A patent/RS58778B1/sr unknown
- 2014-07-30 UA UAA201601716A patent/UA117023C2/uk unknown
- 2014-07-30 EA EA201600143A patent/EA031053B1/ru not_active IP Right Cessation
- 2014-07-30 CA CA2918228A patent/CA2918228C/fr not_active Expired - Fee Related
-
2016
- 2016-08-30 HK HK16110305.1A patent/HK1222167A1/zh not_active IP Right Cessation
- 2016-10-04 HK HK16111559.2A patent/HK1223348A1/zh unknown
-
2019
- 2019-06-19 HR HRP20191119TT patent/HRP20191119T1/hr unknown
- 2019-07-01 CY CY20191100686T patent/CY1122959T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201601363YA (en) | Process for purifying an acid composition comprising 2-formyl-furan-5-carboxylic acid and 2,5-furandicarboxylic acid | |
| HK1232229A1 (zh) | '- '-硫代核苷的新型化合物及其製備方法、藥物組合物和應用 | |
| HRP20181122T1 (hr) | Postupak za pripremu jopamidola | |
| PL3164116T3 (pl) | Kompozycje musujące zawierające kokryształy części kwasowej | |
| ZA201603457B (en) | Novel method for the synthesis of agomelatine | |
| GB2559718B (en) | Novel crystalline form of tribenuron-methyl, process for preparation and use thereof | |
| HK1223348A1 (zh) | 阿戈美拉汀和對甲苯磺酸的共晶的新形式、其製備方法和包含其的藥物組合物 | |
| ZA201504691B (en) | Novel veterinary pharmaceutical compositions and method for the production thereof | |
| GB2561750B (en) | Novel crystalline form of thifensulfuron-methyl, process for preparation and use thereof | |
| HK1223088A1 (zh) | 阿戈美拉汀和磺酸的新複合物、其製備方法和包含其的藥物組合物 | |
| SI2819654T1 (sl) | Postopek za pripravo farmacevtskega sestavka na osnovi modafinila, farmacevtski sestavek, pripravljen s tem postopkom, in njegova uporaba |